articleThe Lancet OncologyFeb 17, 2009GREEN OA

Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data

HIHoward I. ScherXJXiaoyu JiaJSJohann S. de BonoMFMartin FleisherKJKenneth J. Pienta

Memorial Sloan Kettering Cancer Center · Cornell University · +3 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

615
total citations
FWCI
22.79
Percentile
100%
References
23
Citations per year

Authors

7

Topics & keywords

Topics
Keywords
  • Medicine
  • Prostate cancer
  • Hazard ratio
  • Internal medicine
  • Oncology
  • Proportional hazards model
  • Circulating tumor cell
  • Surrogate endpoint
UN Sustainable Development Goals
  • Reduced inequalities
No related works found for this paper.

Funding